Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.
Sign Up to like & getrecommendations! Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106293
Abstract: BACKGROUND Hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) is characterized by recurrent episodes of subcutaneous/submucosal edema, which may be preceded by erythema marginatum (EM) as a prodromal symptom. Our aim was to analyze the changes… read more here.
Keywords: erythema marginatum; symptom free; hae attacks; hereditary angioedema ... See more keywords
Investigational drugs in phase I and phase II clinical trials for hereditary angioedema
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2018.1415325
Abstract: ABSTRACT Introduction: Hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) is a rare bradykinin-mediated disease characterized by recurrent subcutaneous and/or submucosal angioedematous attacks (HAE attacks), which occur unpredictably. The recurrent HAE attacks do not respond to… read more here.
Keywords: phase; hae attacks; hereditary angioedema; clinical trials ... See more keywords